Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RHOA | P61586 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 15/20 | 0.47 |
| ▸ | BTK | Q06187 | 11/20 | 0.47 |
| ▸ | ITK | Q08881 | 5/20 | 0.45 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | LYN | P07948 | 1/20 | 0.44 |
| ▸ | TEC | P42680 | 1/20 | 0.44 |
| ▸ | TXK | P42681 | 1/20 | 0.44 |
| ▸ | BMX | P51813 | 1/20 | 0.44 |
| ▸ | JAK3 | P52333 | 1/20 | 0.44 |
| ▸ | CD69 | Q07108 | 1/20 | 0.44 |
| ▸ | BLK | P51451 | 2/20 | 0.44 |
| ▸ | FLT3 | P36888 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22356433 | 0.97 | RHOA (0.54) | RHOAEGFRBTKITKJAK2 | |
| SCHEMBL22356391 | 0.97 | RHOA (0.54) | RHOAEGFRBTKITKJAK2 | |
| SCHEMBL22356381 | 0.93 | RHOA (0.51) | RHOAEGFRBTKITKBLK | |
| SCHEMBL22356478 | 0.91 | RHOA (0.48) | RHOAEGFRBTKITKJAK2 | |
| SCHEMBL22356482 | 0.91 | MAPT (0.51) | RHOAEGFRBTKITKBLK | |
| SCHEMBL22356450 | 0.91 | MAPT (0.51) | RHOAEGFRBTKITKBLK | |
| SCHEMBL22356446 | 0.91 | MAPT (0.51) | RHOAEGFRBTKITKBLK | |
| SCHEMBL22356481 | 0.91 | MAPT (0.51) | RHOAEGFRBTKITKBLK | |
| SCHEMBL22356325 | 0.91 | EGFR (0.49) | EGFRBLKFLT3 | |
| SCHEMBL22356453 | 0.88 | EGFR (0.48) | RHOAEGFRBTKITK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TREEEL CO., LTD (KR) | 2020-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262798-A1 | NOVEL TRIAZINE DERIVATIVE AND PHOTOSENSITIVE COMPOSITION COMPRISING SAME | TYR, CRY2, CRY1 | RHOA 3916/4885EGFR 2575/4885BTK 1760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.